Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $1.56 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to loss of $1.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -62.50%. A quarter ago, it was expected that this company would post a loss of $0.93 per share when it actually produced a loss of $1.02, delivering a surprise of -9.68%.Over the last four quarters, the company has ...